Pan C J, Sartwell A D, Chou J Y
Human Genetics Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
Cancer Res. 1991 Apr 15;51(8):2058-62.
Human choriocarcinoma cells, the malignant trophoblasts, synthesize germ cell alkaline phosphatase (GCAP) which shares 98% sequence identity with the placental alkaline phosphatase (AP). The two isozymes are immunologically similar but react differentially toward inhibition by L-leucine or EDTA. Administration of sodium butyrate to choriocarcinoma cells greatly increased the transcription rate of the GCAP gene, resulting in an increase in mRNA expression and enzyme biosynthesis. The butyrate-modulated AP induction was blocked by cycloheximide, suggesting that a mediator protein may be involved. Protein sequence deduced from complementary DNA analysis suggests that GCAP contains two potential sites for asparagine (N)-linked glycosylation. The marked increase in GCAP expression by butyrate in choriocarcinoma cells allowed us to study the extent of N-linked glycosylation and its role on GCAP enzyme activity. After limited tunicamycin treatment, Mr 65,000 (fully processed), Mr 58,000 (nonglycosylated), and Mr 62,000 polypeptides were synthesized by these cells in the presence of butyrate. This suggests that the Mr 62,000 product may be the singly glycosylated GCAP monomer and that both sites are glycosylated in this phosphatase. The glycosylated and nonglycosylated GCAPs, synthesized by butyrate-treated choriocarcinoma cells in the absence or presence of tunicamycin, respectively, were similarly inhibited by L-leucine or EDTA. Moreover, the specific enzyme activity of glycosylated and nonglycosylated GCAP remained unchanged, indicating that AP lacking N-linked oligosaccharide side chains was catalytically active. This is supported by the finding that nonglycosylated GCAP incorporated inorganic phosphate which binds to the active site of AP. Since the active form of AP is a homodimer, our data indicate that the glycan moieties are not required for the dimerization and catalytic activity of GCAP.
人绒毛膜癌细胞,即恶性滋养层细胞,能合成与胎盘碱性磷酸酶(AP)有98%序列同一性的生殖细胞碱性磷酸酶(GCAP)。这两种同工酶在免疫上相似,但对L-亮氨酸或乙二胺四乙酸(EDTA)抑制的反应不同。向绒毛膜癌细胞中加入丁酸钠可显著提高GCAP基因的转录速率,导致mRNA表达增加和酶生物合成增加。丁酸盐调节的AP诱导被放线菌酮阻断,这表明可能涉及一种介导蛋白。从互补DNA分析推导的蛋白质序列表明,GCAP含有两个潜在的天冬酰胺(N)-连接糖基化位点。丁酸盐使绒毛膜癌细胞中GCAP表达显著增加,这使我们能够研究N-连接糖基化的程度及其对GCAP酶活性的作用。在有限的衣霉素处理后,这些细胞在丁酸盐存在的情况下合成了分子量为65000(完全加工)、58000(非糖基化)和62000的多肽。这表明分子量为62000的产物可能是单糖基化的GCAP单体,且该磷酸酶的两个位点均被糖基化。分别在不存在或存在衣霉素的情况下,由丁酸盐处理的绒毛膜癌细胞合成的糖基化和非糖基化GCAP,同样受到L-亮氨酸或EDTA的抑制。此外,糖基化和非糖基化GCAP的比酶活性保持不变,表明缺乏N-连接寡糖侧链的AP具有催化活性。这一发现得到了支持,即非糖基化的GCAP掺入了与AP活性位点结合的无机磷酸盐。由于AP的活性形式是同二聚体,我们的数据表明聚糖部分对于GCAP的二聚化和催化活性不是必需的。